Trial NCT02391545

View at ClinicalTrials.gov 
Org. Study IDs: IPI-145-19
Secondary IDs: 2014-005459-13

Last trial update was posted on 2023-09-28

MeSH Interventions

Obinutuzumab Rituximab

MeSH Conditions

Lymphoma Lymphoma, Follicular

Other Conditions

CD20+ Follicular Lymphoma

Stopping Reasons

Sponsor is focusing on studies which can enable registration of duvelisib.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID